50
Participants
Start Date
May 31, 2014
Primary Completion Date
May 31, 2025
Study Completion Date
November 30, 2025
Dose
The outcomes of reducing to half of the topical steroid (i.e. fluticasone \[Flovent\] and Swallowed viscous budesonide \[Pulmicort\]) will be observed with regards to whether the patients continue to be in histologic remission. These patients will have already achieved remission on a full dose of the steroid.
Ann & Robert H Lurie Childjren's Hospital of Chicago, Chicago
Ann & Robert H Lurie Children's Hospital of Chicago
OTHER